Results 221 to 230 of about 84,272 (327)
This study explored how a 90‐day nutraceutical blend with prebiotics, minerals, and silymarin affects the gut‐brain axis in overweight adults. Results showed improved gut microbiota, reduced inflammation, and better sleep, mood, and quality of life, suggesting a strong link between gut health and mental well‐being.
Aline Boveto Santamarina+15 more
wiley +1 more source
Systematic Review on the Management of Chronic Constipation in North America [PDF]
Lawrence J. Brandt+5 more
openalex +2 more sources
TEGASEROD IS SAFE AND WELL TOLERATED IN PATIENTS WITH CHRONIC CONSTIPATION: RESULTS FROM A 12-WEEK MULTINATIONAL STUDY [PDF]
Sophie Hugot+9 more
openalex +1 more source
Effect of Natural Polyphenols on Breast Cancer Chemoprevention and Treatment
Effect of Natural Polyphenols on Breast Cancer proliferation and progression. ABSTRACT Breast cancer is the most common type of malignancy among women worldwide. Significant achievements have been made in diagnostic tools and cancer treatments in the past decade; however, the complexity and heterogeneity of certain breast cancer subtypes often lead to ...
Marzia Sichetti+4 more
wiley +1 more source
ABSTRACT Introduction/Aims Hereditary transthyretin amyloidosis (ATTRv) is an autosomal dominant multisystem disorder that occurs worldwide. The most common mutation in the United States, V142I, has previously been described as having a primarily cardiac presentation.
Urvi Desai+3 more
wiley +1 more source
Chronic Constipation and Fecal Incontinence in Children with Neurological and Neuromuscular Handicap
Carlo Di Lorenzo
openalex +1 more source
Prospective, randomized, parallel‐group trial to evaluate the effects of lactulose and polyethylene glycol‐4000 on colonic flora in chronic idiopathic constipation [PDF]
Yoram Bouhnik+8 more
openalex +1 more source
ABSTRACT Introduction/Aims Edaravone intravenous (IV) and oral suspension have been shown to have similar pharmacokinetics, safety, and slowing of functional decline in patients with amyotrophic lateral sclerosis (ALS). Study MT‐1186‐A01 indicated that edaravone oral suspension was well‐tolerated over 48 weeks, with no new safety concerns identified ...
Angela Genge+17 more
wiley +1 more source